Todos Medical Enters Into Definitive Agreement With Orot+ for Exclusive Distribution Rights of its Breast Cancer Screening Tests in 2 European Countries

Tuesday, April 16, 2019

Todos Medical Ltd  a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of cancer and neurodegenerative disorders such as Alzheimer's disease, today announced the signing of a Distribution Agreement with Orot+, the operational division of Orot-Luces (http://orot-luces.com), for exclusive distribution rights of Todos Medical Ltd.’s innovative and cost-effectiveTM-B2 blood tests for breast cancer screening in the European territories of Romania and Austria.

“Since inception, Todos Medical has worked diligently to bring our breast cancer screening technology to commercialization to help patients and their physicians identify cancer earlier in the disease process using a simple blood test,” said Dr. Herman Weiss, Todos Medical’s CEO. “Today, we are happy to announce the signing of a Distribution Agreement with Orot+ to act as the exclusive distributor of Todos Medicals breast cancer screens in Austria and Romania. Establishing a local network to introduce our cancer screening tests to the European market is an important milestone for Todos Medical.”

“We are excited at the opportunity to bring Todos Medicals simple blood test for the early detection of breast cancer to Austria and Romania,” said Mr. Ron Streichman, Orot-Luces group’s CEO. “We believe that our experienced team and established network will be instrumental in making our vision to give cancer patients access to innovative solutions, a better chance at long term survival, resulting in a better quality of life. We look forward to working with Todos for many years to come.”

Orot+ will be responsible for marketing and distribution costs and execution associated with commercializing the breast cancer tests in Romania and Austria. Todos Medical will be able to use the data gathered from these initiatives to support further development and commercialization in other jurisdictions.